Revvityブログ
発見から治療までのイノベーションを促進
Latest
From policy to practice: what FDA's 2025 direction means for your precision medicine pipeline.
Cell and Gene Therapy
December 8, 2025 - 5 min read
Cell and Gene Therapy
Exploring the potential of base editing for sickle cell disease.
February 14, 2025 -
4 min read
Cell and Gene Therapy
Revvity supports Abata Therapeutics to impact the trajectory of autoimmune disease with engineered Treg cell therapies.
February 7, 2025 -
1 min read
Disease Research
What to consider when selecting a centrifuge for your lab.
January 24, 2025 -
3 min read
Cancer
Considerations for engineering a successful knockout cell line generation.
January 17, 2025 -
1 min read
Cancer
Homology-directed repair with a plasmid donor: considerations for successful HDR experimental design.
January 15, 2025 -
4 min read
Cancer
Homology-directed repair with a DNA donor oligo: considerations for successful HDR experimental design.
January 14, 2025 -
5 min read
Agricultural Genomics
Quality assessment of ngs imputation results in agrigenomics.
January 6, 2025 -
6 min read
Agricultural Genomics
The logic behind imputation analysis in next-generation sequencing for agrigenomics.
January 6, 2025 -
5 min read
